Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $37.8300 (3.64%) ($36.5400 - $37.8400) on Tue. Mar. 26, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.29% (three month average) | RSI | 57 | Latest Price | $37.8300(3.64%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.8% a day on average for past five trading days. | Weekly Trend | ATRA advances 0.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.145% in a week (0% probabilities). VXX(-13%) UUP(-13%) TLT(-13%) VIXM(-11%) UNG(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.145% (StdDev 4.29%) | Hourly BBV | 0 () | Intraday Trend | 2.3% | | | |
|
Resistance Level | $38.12 | 5 Day Moving Average | $38.12(-0.76%) | 10 Day Moving Average | $38.66(-2.15%) | 20 Day Moving Average | $38.12(-0.76%) | To recent high | -9.4% | To recent low | 33.2% | Market Cap | $2.811b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |